Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-28 · accession 0001127602-22-007175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-28 | 2022-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | +30.1K | 24.8K | New | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | F - Tax | $2.85 | -8,261 | 21.9K | -27% | -$23.5K |
| DM | 2022-02-28 | 2022-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | -30.1K | 10.6K | -74% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-28 | M | A | 5,287 | — | 30,128 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2022-02-28 | M | A | 10,007 | — | 10,007 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2022-02-28 | F | D | 8,261 | $2.85 | 21,867 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-28 | M | A | 14,834 | — | 24,841 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2022-02-28 | M | D | 14,834 | — | 14,833 | D | — · — to — | 14,834 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F4) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2022-02-28 | M | D | 10,007 | — | 0 | D | — · — to — | 10,007 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter. |
| 7 | Derivative | Restricted Stock Units | 2022-02-28 | M | D | 5,287 | — | 10,573 | D | — · — to — | 5,287 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F4) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |